ArticlePharmaceuticals (Basel, Switzerland)2021

Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's Disease.

José M Alonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.